J&J Vision Introduces VERITAS Vision System

Johnson & Johnson Vision,* a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies,† has unveiled the VERITAS Vision System, a next-generation phacoemulsification (phaco) system designed to address three critical areas: patient safety, surgeon efficiency and comfort.
 
Approximately 50 percent of people over the age of 75 have cataracts¹ and cataract surgery is one of the most common outpatient procedures performed today with a success rate of approximately 98 percent.² Phacoemulsification is the most common cataract surgery technique³ and allows surgeons to effectively emulsify and efficiently remove the eye’s internal lens when it has become cloudy from cataracts.‡ It is a delicate procedure that requires significant effort and control, which can be taxing on the surgeon. Equipment that surgeons can rely on through surgery is critical to optimizing the circumstances for surgical success.
 
“In my experience, the advancements in fluidics management and usability of the VERITAS Vision System have made a marked improvement in safety and stability of the phaco procedure,” said Jason Jones, M.D.§, Jones Eye Clinic, Sioux City, Iowa. “I’ve found I can glide through any lens density with less surge, and the level of chamber stability I’ve experienced with VERITAS gives me more confidence to take advantage of Venturi mode, the more powerful phaco setting.”     
 
“Surgeon-centered equipment design is vital for an exacting and taxing procedure like phacoemulsification,” said Dr. Marco Tavolato, head of Eye Centre, Chioggia Hospital, Italy.** “The advancements Johnson & Johnson Vision has made in phaco technology reinforce that the company is listening and tailoring innovations to surgeons’ needs. From safety features like Hybrid Fluidics Technology, to the nuances of a more ergonomic design for comfort and control, these advancements have made a measurable difference in my surgical day, and ease even the most challenging phaco cases.” 
 
The VERITAS Vision System features several innovations to provide a better surgical experience, including:

• Less surge, more stability
• Hybrid Fluidics Technology minimizes post-occlusion surge to protect intraocular structures and provide exceptional chamber stability.††,‡‡
• Intelligent Occlusion Sensing Technologies automatically respond to occlusions to preserve a calm, stable chamber even in dense cataract cases.§§
• Exceptional phacoemulsification efficiency
• Built using the company’s leading WHITESTAR technology combined with elliptical tip movement for ultra-smooth cutting, even in dense or advanced cataracts, providing an efficient lens extraction that uses less energy.***
• Dual Pump System allows access to both Peristaltic and Venturi pumps with on-demand transition between the two at every step, allowing surgeons to adapt to clinical needs.‡‡
• Surgeon-centered ergonomics for maneuverability and comfort
• Between 52 percent and 80 percent of ophthalmologists report back and neck pain because of their work⁴ and 43 percent take breaks during surgery due to pain.⁵
• An ergonomically designed foot pedal provides total control and a more comfortable experience.†††

 
“On top of providing a safe and stable procedure for cataract patients, we wanted to also offer a more efficient and comfortable phacoemulsification experience for surgeons, especially knowing most will perform multiple cataract surgeries every day,” said Warren Foust, worldwide president, Surgical at Johnson & Johnson Vision.‡‡‡ “Our VERITAS Vision System delivers high-performing, reliable tools for a smooth, effective cataract surgery for patients while also prioritizing surgeon well-being.”
 
The VERITAS Vision System is the latest addition to the company’s full suite of industry leading products for the treatment of cataracts. The global launch comes as the Johnson & Johnson Vision celebrates two 20-year anniversaries: WHITESTAR micropulse technology, a major advancement in phacoemulsification efficiency, and the TECNIS Family of IOLs, which established the company’s legacy of innovation in cataract treatment. 
 
The VERITAS Vision System is now available for ophthalmologists across the United States, Europe and select markets in the Asia Pacific region to use in their treatment of cataracts and will be available later this year in Chile and Brazil. 
 
Johnson & Johnson Vision, part of Johnson & Johnson Medical Devices Companies, wants to change the trajectory of eye health worldwide. Through its operating companies, the organization delivers innovation that enables eye care professionals to create better outcomes for patients throughout their lives, with products and technologies that address unmet needs including refractive error, cataracts, and dry eye. In communities with greatest need, J&J Vision works in collaboration to expand access to quality eye care. 

Johnson & Johnson Medical Devices Companies tackles pressing healthcare challenges, and takes bold steps that lead to new standards of care while improving people’s healthcare experiences. In surgery, orthopaedics, vision, and interventional solutions, Johnson & Johnson Medical Devices Companies help save lives and pave the way to a healthier future.

References 
¹ National Eye Institute. Cataract Data and Statistics. https://www.nei.nih.gov/eyedata/cataract 
² Vision Health Initiative, Common Eye Disorders. Centers for Disease Control and Prevention. https://www.cdc.gov/visionhealth/basics/ced/index.html  
³ The Journal of the Missouri State Medical Association. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139750/  
⁴ Honavar SG (2017) Head up, heels down, posture perfect: Ergonomics for an ophthalmologist. Indian J Ophthalmol 65 (8: 647-650).
⁵ Soueid A, Oudit D, Thiagarajah S, Laitung G (2010) The pain of surgery: pain experienced by surgeons while operating. Int J Surg 8 (2): 118-120.
* Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
† The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, vision, and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment
‡ As with any medical procedure, risks and potential complications may occur. Please consult your eye care specialist for detailed information and to discuss these possible risks and complications with you prior to the procedure.
§ Dr. Jones is a consultant for Johnson & Johnson Surgical Vision, Inc.
** Dr. Tavolato is a consultant for Johnson & Johnson Surgical Vision in EMEA
†† DOF2021OTH4006 R&D Memo – Design Intent for VERITAS Vision System
‡‡ Z370584 VERITAS Operator Manual Rev E. page 1-6, 1-8, 1-9, 3-7
§§ Z370584 VERITAS Operator Manual Rev E. page 1-5, 1-9, 1-11, 6-27, 6-33
*** DOF2021OTH4005 VERITAS Vision System Features
††† DOF2021OTH4004 VERITAS foot pedal ergonomic improvements
‡‡‡ Warren Foust is the Worldwide President of Johnson & Johnson Vision overseeing the Surgical Vision organization